35089797|t|Inhibition of sphingolipid de novo synthesis counteracts muscular dystrophy.
35089797|a|Duchenne muscular dystrophy (DMD), the most common muscular dystrophy, is a severe muscle disorder, causing muscle weakness, loss of independence, and premature death. Here, we establish the link between sphingolipids and muscular dystrophy. Transcripts of sphingolipid de novo biosynthesis pathway are up-regulated in skeletal muscle of patients with DMD and other muscular dystrophies, which is accompanied by accumulation of metabolites of the sphingolipid pathway in muscle and plasma. Pharmacological inhibition of sphingolipid synthesis by myriocin in the mdx mouse model of DMD ameliorated the loss in muscle function while reducing inflammation, improving Ca2+ homeostasis, preventing fibrosis of the skeletal muscle, heart, and diaphragm, and restoring the balance between M1 and M2 macrophages. Myriocin alleviated the DMD phenotype more than glucocorticoids. Our study identifies inhibition of sphingolipid synthesis, targeting multiple pathogenetic pathways simultaneously, as a strong candidate for treatment of muscular dystrophies.
35089797	14	26	sphingolipid	Chemical	MESH:D013107
35089797	57	75	muscular dystrophy	Disease	MESH:D009136
35089797	77	104	Duchenne muscular dystrophy	Disease	MESH:D020388
35089797	106	109	DMD	Disease	MESH:D020388
35089797	128	146	muscular dystrophy	Disease	MESH:D009136
35089797	160	175	muscle disorder	Disease	MESH:D009135
35089797	185	200	muscle weakness	Disease	MESH:D018908
35089797	202	222	loss of independence	Disease	MESH:D064129
35089797	228	243	premature death	Disease	MESH:D003643
35089797	281	294	sphingolipids	Chemical	MESH:D013107
35089797	299	317	muscular dystrophy	Disease	MESH:D009136
35089797	334	346	sphingolipid	Chemical	MESH:D013107
35089797	415	423	patients	Species	9606
35089797	429	432	DMD	Disease	MESH:D020388
35089797	443	463	muscular dystrophies	Disease	MESH:D009136
35089797	524	536	sphingolipid	Chemical	MESH:D013107
35089797	597	609	sphingolipid	Chemical	MESH:D013107
35089797	623	631	myriocin	Chemical	MESH:C001996
35089797	643	648	mouse	Species	10090
35089797	658	661	DMD	Disease	MESH:D020388
35089797	717	729	inflammation	Disease	MESH:D007249
35089797	741	745	Ca2+	Chemical	-
35089797	770	778	fibrosis	Disease	MESH:D005355
35089797	882	890	Myriocin	Chemical	MESH:C001996
35089797	906	909	DMD	Disease	MESH:D020388
35089797	982	994	sphingolipid	Chemical	MESH:D013107
35089797	1102	1122	muscular dystrophies	Disease	MESH:D009136
35089797	Negative_Correlation	MESH:C001996	MESH:D020388
35089797	Association	MESH:D013107	MESH:D009136
35089797	Negative_Correlation	MESH:C001996	MESH:D007249
35089797	Negative_Correlation	MESH:C001996	MESH:D013107
35089797	Negative_Correlation	MESH:C001996	MESH:D005355
35089797	Association	MESH:D013107	MESH:D020388

